A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques | Nature Medicine
COVID-19 vaccine booster produces strong responses in people with HIV with low CD4 counts | aidsmap
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
Top in ID: Second COVID-19 booster, ivermectin, long-acting HIV regimen
HIV and COVID-19: What You Should Know | HIV.gov
COVID-19 vaccines in people with HIV | aidsmap
COVID-19 Spring Booster Vaccine for Those Living With HIV - NHS Sexual Health Tayside
First mRNA HIV Vaccines Are Given in New Phase 1 Clinical Trial | Everyday Health
Four Years After Last Shot, HIV Vaccine Booster Prompts Immune Response - POZ
What is the impact of SARS-CoV-2 on HIV-1 infectivity?
HIV: What to Know About Supplements | Everyday Health
Vaccines | Free Full-Text | Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH) | BMC Infectious Diseases | Full Text
Higher Risk of Severe Breakthrough COVID for Certain HIV Patients | MedPage Today
Important information about COVID-19 boosters and availability
Vaccines | Free Full-Text | Protection of Vaccine Preventable Diseases in a Population of HIV-Infected Children: A 3 Years Prospective Study
Booster vaccination can reduce breakthrough infection risk in HIV patients
Frontiers | Boosting the Immune System for HIV Cure: A γδ T Cell Perspective
COVID-19 vaccine and booster highly effective in people with HIV, large studies show | aidsmap
New HIV Vaccine Booster Prompts Long-Lived Immune Response in Monkeys - POZ
Get your spring booster COVID shot, British HIV Association advises everyone with HIV | aidsmap
Hiv Positive: Covid boosters leading to positive HIV test? Experts debunk claim - The Economic Times
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
Kementerian Komunikasi dan Informatika
Progress toward an eventual HIV vaccine | National Institutes of Health (NIH)
